🚀 VC round data is live in beta, check it out!
AcouSort Valuation Multiples
Discover revenue and EBITDA valuation multiples for AcouSort and similar public comparables like Nanologica, GenIP, Fluicell, AnteoTech and more.
AcouSort Overview
About AcouSort
AcouSort AB is a company that specializes in products and solutions for the automated preparation of biological samples for researchers and life science companies. Its technology is based on using ultrasound to isolate, separate, or trap microscopic particles such as blood cells, bacteria, or extracellular vesicles in microfluidic channels. The company's products include AcouTrap, AcouWash, and AcouPlasma.
Founded
2010
HQ
Employees
16
Website
Sectors
Financials (LTM)
EV
$6M
AcouSort Financials
AcouSort reported last 12-month revenue of $886K and negative EBITDA of ($1M).
In the same LTM period, AcouSort generated $886K in gross profit, ($1M) in EBITDA losses, and had net loss of ($1M).
Revenue (LTM)
AcouSort P&L
In the most recent fiscal year, AcouSort reported revenue of $764K and EBITDA of ($1M).
AcouSort expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $886K | XXX | $764K | XXX | XXX | XXX |
| Gross Profit | $886K | XXX | $736K | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 96% | XXX | XXX | XXX |
| EBITDA | ($1M) | XXX | ($1M) | XXX | XXX | XXX |
| EBITDA Margin | (130%) | XXX | (152%) | XXX | XXX | XXX |
| EBIT Margin | (135%) | XXX | (156%) | XXX | XXX | XXX |
| Net Profit | ($1M) | XXX | ($1M) | XXX | XXX | XXX |
| Net Margin | (146%) | XXX | (174%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
AcouSort Stock Performance
AcouSort has current market cap of $7M, and enterprise value of $6M.
Market Cap Evolution
AcouSort's stock price is $0.34.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6M | $7M | 0.3% | XXX | XXX | XXX | $-0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAcouSort Valuation Multiples
AcouSort trades at 7.3x EV/Revenue multiple, and (5.6x) EV/EBITDA.
EV / Revenue (LTM)
AcouSort Financial Valuation Multiples
As of April 19, 2026, AcouSort has market cap of $7M and EV of $6M.
Equity research analysts estimate AcouSort's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
AcouSort has a P/E ratio of (5.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $7M | XXX | $7M | XXX | XXX | XXX |
| EV (current) | $6M | XXX | $6M | XXX | XXX | XXX |
| EV/Revenue | 7.3x | XXX | 8.5x | XXX | XXX | XXX |
| EV/EBITDA | (5.6x) | XXX | (5.6x) | XXX | XXX | XXX |
| EV/EBIT | (5.4x) | XXX | (5.4x) | XXX | XXX | XXX |
| EV/Gross Profit | 7.3x | XXX | 8.8x | XXX | XXX | XXX |
| P/E | (5.5x) | XXX | (5.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (3.4x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified AcouSort Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
AcouSort Margins & Growth Rates
AcouSort's revenue in the last 12 month grew by 65%.
AcouSort's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.1M for the same period.
AcouSort's rule of 40 is (36%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
AcouSort's rule of X is 50% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
AcouSort Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 65% | XXX | 54% | XXX | XXX | XXX |
| EBITDA Margin | (130%) | XXX | (152%) | XXX | XXX | XXX |
| EBITDA Growth | (16%) | XXX | (6%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (36%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 50% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 252% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
AcouSort Public Comps
See public comps and valuation multiples for other Life Sciences Tools comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| AcouSort | XXX | XXX | XXX | XXX | XXX | XXX |
| Nanologica | XXX | XXX | XXX | XXX | XXX | XXX |
| GenIP | XXX | XXX | XXX | XXX | XXX | XXX |
| Fluicell | XXX | XXX | XXX | XXX | XXX | XXX |
| AnteoTech | XXX | XXX | XXX | XXX | XXX | XXX |
| Harvard Apparatus | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AcouSort M&A Activity
AcouSort acquired XXX companies to date.
Last acquisition by AcouSort was on XXXXXXXX, XXXXX. AcouSort acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by AcouSort
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAcouSort Investment Activity
AcouSort invested in XXX companies to date.
AcouSort made its latest investment on XXXXXXXX, XXXXX. AcouSort invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by AcouSort
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout AcouSort
| When was AcouSort founded? | AcouSort was founded in 2010. |
| Where is AcouSort headquartered? | AcouSort is headquartered in Sweden. |
| How many employees does AcouSort have? | As of today, AcouSort has over 16 employees. |
| Is AcouSort publicly listed? | Yes, AcouSort is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of AcouSort? | AcouSort trades under ACOU ticker. |
| When did AcouSort go public? | AcouSort went public in 2020. |
| Who are competitors of AcouSort? | AcouSort main competitors are Nanologica, GenIP, Fluicell, AnteoTech. |
| What is the current market cap of AcouSort? | AcouSort's current market cap is $7M. |
| What is the current revenue of AcouSort? | AcouSort's last 12 months revenue is $886K. |
| What is the current revenue growth of AcouSort? | AcouSort revenue growth (NTM/LTM) is 65%. |
| What is the current EV/Revenue multiple of AcouSort? | Current revenue multiple of AcouSort is 7.3x. |
| Is AcouSort profitable? | No, AcouSort is not profitable. |
| What is the current EBITDA of AcouSort? | AcouSort has negative EBITDA and is not profitable. |
| What is AcouSort's EBITDA margin? | AcouSort's last 12 months EBITDA margin is (130%). |
| What is the current EV/EBITDA multiple of AcouSort? | Current EBITDA multiple of AcouSort is (5.6x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.